Trial Profile
Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Acronyms PROTECT
- Sponsors AbbVie
- 18 Jun 2014 New trial record
- 10 Feb 2012
- 10 Nov 2010